Motivation and frustration in cardiology trial participation: the patient perspective

Area of Science:

• Cardiovascular Medicine
• Clinical Trial Research
• Patient-Centric Studies

Background:

• Human participation in clinical cardiology trials is crucial for advancing medical knowledge.
• Understanding participant motivations and frustrations is vital for improving trial design and recruitment.
• Limited data exists on patient perceptions of their involvement in cardiology studies.

Purpose of the Study:

• To investigate the primary motivators for patient participation in hypertension and coronary arterial disease clinical trials.
• To identify factors contributing to participant frustration and potential withdrawal from these trials.

Main Methods:

• A questionnaire-based study involving 80 patients who previously participated in phases II, III, or IV clinical trials.
• Participants were categorized into two groups: placebo-controlled trials (Group I) and active-controlled trials with a placebo washout (Group II).
• Data collected on socio-demographic characteristics, motivations, and reasons for withdrawal.

Main Results:

• The primary motivation for participation in approximately 60% of patients was the expectation of personal health benefits.
• Reasons for withdrawal included perceived risks in placebo-controlled trials (Group I) and the burden of frequent institutional visits (Group II).
• Fear of discontinuing hospital treatment was not a significant factor for patient withdrawal.

Conclusions:

• The potential for therapeutic benefit remains a strong driver for patient enrollment in cardiology clinical trials.
• Addressing participant concerns regarding perceived risks and logistical burdens is essential for trial retention.
• Future trial designs should consider patient-reported outcomes and experiences to enhance engagement.